Indice del forum ECONOMIA PARALLELA
AREA LIBERA


Per riflettere e prepararsi
all'Emissione Monetaria Diretta
 FAQFAQ   CercaCerca   Lista utentiLista utenti   GruppiGruppi   RegistratiRegistrati 
 ProfiloProfilo   Messaggi privatiMessaggi privati   ConnettiConnetti 

Renub Research | Global Vaccine Market Forecast

 
Nuovo argomento   Rispondi    Indice del forum -> Comunicazioni
Precedente :: Successivo  
Autore Messaggio
BillyJhon



Registrato: 05/07/19 07:31
Messaggi: 15

MessaggioInviato: Mar Lug 16, 2019 6:21 am    Oggetto: Renub Research | Global Vaccine Market Forecast Rispondi citando

Vaccines are saving millions of lives every year, but many million lives can also be saved yearly with better global vaccine coverage. Vaccines are a vital component of the family and public health. Vaccine prevent the spreading of dangerous, contagious and even deadly diseases, vaccination plays an important role in prevention from diseases. The immune system of children and elderly is much weaker than young adults, and they are particularly more susceptible to dangerous infections. There are numerous diseases including measles, polio, chickenpox, mumps, whooping cough, HPV, diphtheria, etc. which can be prevented by timely vaccination. But still there are some misunderstandings and confusion about vaccination due to which few individuals in some countries opposes to get vaccinated. According to Renub Research analysis, the Global Vaccine Market is forecasted to be US$ 70 Billion by the end of the year 2024.



Vaccines are better than medicine, as drug resistance can be caused by medicine due to overuse and misuse of drugs. By preventing infections that would require drug treatments, vaccines reduce the opportunity for drug resistance to develop. Global vaccination market is growing due to increasing government and non-government funding, rising prevalence of diseases, increasing investment and continuous research and development of new vaccines by healthcare companies like GlaxoSmithKline, Merck, Sanofi and Pfizer.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=global-vaccines-market-and-forecast-14-vaccines-market-number-of-people-immunized-doses-of-vaccines-administered-1200-p.php

The vaccine is a safe and effective biological preparation, which improves the immunity against a particular disease. Technological advancement, rising demand for low cost products and widespread routine immunization programmes in several countries around the world will certainly expect to stimulate the growth of the vaccine market in the following years. Also, rising demand for combinations vaccines as it provides immunization against several diseases in a single shot is further expected to boost the vaccine business growth.

By Disease - Pneumococcal Vaccine is likely to grow at noteworthy rate over the coming years

The report studies the market of the following vaccine: Influenza, Cervical Cancer, Zoster (Shingles), MMR (Measles, Mumps, and Rubella), Pneumonia, Meningitis, Hepatitis, Tap (Diphtheria, Tetanus, Pertussis), Haemophilus influenzae type B (Hib), Polio, Rotavirus, Varicella, Combination Vaccine, Travel & Miscellaneous Vaccine. Influenza, Pneumococcal, Meningococcal, Hepatitis and Combination Vaccines together hold the significant market share and is expected to continue so.

Request a free sample copy of the report: https://www.renub.com/request-brochure-page.php?gturl=global-vaccines-market-and-forecast-14-vaccines-market-number-of-people-immunized-doses-of-vaccines-administered-1200-p.php

By End User Infants (Pediatric) Segment leads the Global Vaccine Market

The report studies the market by end user as Infants (Pediatric) and Adults. It is found that the market for Infants (Pediatric) segment is huge because as most of the countries now have included a series of vaccines to their National Immunization Programme as the per WHO recommendations. For the year 2017; Combos (Combination Vaccines) has the maximum immunization share among all pediatric vaccines (Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Haemophilus Influenzae Type b(Hib), Polio, Rotavirus, Varicella) studied in the report as they protect against more ailments in single shot, people preferring to get combination vaccine instead of a specific vaccine.

Company Analysis

GlaxoSmithKline, Merck, Sanofi, and Pfizer are some of the top companies that deal efficiently in vaccine business globally. These companies have been studied thoroughly in the report.

Administration of Vaccine Doses

Our analysis found that there is a consistent surge in the number of Pneumococcal and Meningococcal vaccine doses administration in future due to the rising concern against the life-threatening vaccine-preventable diseases around the world.


Contact Us:
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com
Address: 225 Kristie Ln, Roswell, GA 30076, United States



Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Top
Profilo Invia messaggio privato HomePage
Mostra prima i messaggi di:   
Nuovo argomento   Rispondi    Indice del forum -> Comunicazioni Tutti i fusi orari sono GMT
Pagina 1 di 1

 
Vai a:  
Puoi inserire nuovi argomenti
Puoi rispondere a tutti gli argomenti
Non puoi modificare i tuoi messaggi
Non puoi cancellare i tuoi messaggi
Non puoi votare nei sondaggi


Powered by phpBB Group© 2001, 2005 phpBB.it
phpbb.it